Toggle navigation
Home
Search
Services
Blog
Contact
About
Early Therapeutics Development with Phase 2 Emphasis-261017102
The University of Chicago
Search grants from The University of Chicago
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
University of California San Francisco
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Postdoctoral Training in Developmental Disabilities Research
Time course of spoken word recognition
Epidemiology and Significance of P carinii Colonization
Evidentiary Injury Findings after Sexual Assault
Allergy Prevention By lgE Cytotoxic Peptide(ECP)Vaccine
Recently added grants:
Pathogenic mechanisms of sinonasal sarcoma, a novel gender dimorphic cancer
Collaborative genomic alterations and transcriptional control in prostate cancer
Transcriptional Mechanism of BRD4 in Solid Tumor
Identify tumor suppressor driver genes of pancreatic ductal adenocarcinoma
The molecular and immune evolution in the progression of lung neoplasia to invasive adenocarcinoma
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA017102-005
Application #
6688651
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2002
Total Cost
Indirect Cost
Institution
Name
The University of Chicago
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2005
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017102
/ The University of Chicago
NIH 2004
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017102
/ The University of Chicago
NIH 2003
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017102
/ The University of Chicago
NIH 2002
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017102
/ The University of Chicago
Comments
Be the first to comment on this grant